Binge Ethanol Exposure Increases Liver Injury in Obese Rats

Gastroenterology

Volumn 125, Issue 6, 2003, Pages 1818-1833

  Carmiel Haggai, Michal ^a,b   Cederbaum, Arthur I ^a   Nieto, Natalia ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ADENOSINE TRIPHOSPHATE; ALANINE AMINOTRANSFERASE; ALCOHOL; CASPASE 3; CASPASE 8; CATALASE; CYTOCHROME P450 2E1; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; FAS LIGAND; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE; UNCOUPLING PROTEIN 2;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRINKING BEHAVIOR; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INDUCTION; ENZYME REGULATION; GENOTYPE; LEAN BODY WEIGHT; LIPID PEROXIDATION; LIVER INJURY; MALE; NICK END LABELING; NITROSATION; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; STAINING;

EID: 0345059393     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2003.09.019     Document Type: Article

References (76)

1. Braillon A, Capron JP, Herve MA, Degott C, Quenum C. Liver in obesity. Gut 1985;26:133-139.
2. Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 1979;67:811-816.
3. Lin HZ, Yang SQ, Zeldin G, Diehl AM. Chronic ethanol consumption induces the production of tumor necrosis factor-alpha and related cytokines in liver and adipose tissue. Alcohol Clin Exp Res 1998;22(5 Suppl):231S-237S.
4. Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 1989;20:594-600.
5. Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990;11:74-80.
6. Bacon B, Fraavash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994;107:1103-1109.
7. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-438.
8. Diehl AM, Goodman Z, Ishak KG. Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988;95:1056-1061.
9. Galambos J. Natural history of alcoholic hepatitis. 3. Histological changes. Gastroenterology 1972;63:1026-1032.
10. Pares A, Caballeria J, Brugera M. Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. J Hepatol 1986;2:33-38.
11. Teramoto K, Bowers JL, Kruskal JB, Clouse ME. Hepatic microcirculatory changes after reperfusion in fatty and normal liver transplantation in the rat. Transplantation 1993;56:1076-1082.
12. Seifalian AM, Chidambaram V, Rolles K, Davidson BR. In vivo demonstration of impaired microcirculation in steatotic human liver grafts. Liver Transplant Surg 1998;4:71-77.
13. Hui AM, Kawasaki S, Makuuchi M, Nakayama J, Ikegami T, Miyagawa S. Liver injury following normothermic ischemia in steatotic rat liver. Hepatology 1994;20:1287-1293.
14. Rashid A, Wu TC, Huang CC, Chen CH, Lin HZ, Yang SQ, Lee FY. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 1999;29:1131-1138.
15. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A 1997;94:2557-2562.
16. Day CP, James OFW. Hepatic steatosis: an innocent bystander or guilty party. Hepatology 1998;27:1463-1466.
17. Koneru B, Reddy MC, dela Torre AN, Patel D, Ippolito T, Ferrante RJ. Studies of hepatic warm ischemia in the obese Zucker rat. Transplantation 1995;59:942-946.
18. Hezode C, Lonjon I, Roudot-Thoraval F, Pawlotsky JM, Zafrani ES, Dhumeaux D. Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study. Aliment Pharmacol Ther 2003;17:1031-1037.
19. Tsukamoto H, Lu SC. Current concepts in the pathogenesis of alcoholic liver disease. FASEB J 2001;15:1335-1349.
20. Nanji AA, Zhao S, Sadrzadeh SMH, Dannenberg AJ, Tahan SR, Waxman DJ. Markedly enhanced cytochrome P4502E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol-fed rats. Alcohol Clin Exp Res 1994;18:1280-1285.
21. Morimoto M, Zern MA, Hagbjorrk AL, Ingelman-Sundberg M, French SW. Fish oil, alcohol and liver pathology: role of cytochrome P4502E1. Proc Soc Exp Biol Med 1994;207:197-205.
22. Zhong Z, Arteel G, Connor HD, Schemmer P, Chou SC, Raleigh JA, Mason RP, Lemasters JJ, Thurman RG. Binge drinking disturbs hepatic microcirculation after transplantation: prevention with free radical scavengers. J Pharmacol Exp Ther 1999;290:611-620.
23. Demeilliers C, Maisonneuve C, Grodet A, Mansouri A, Nguyen R, Tinel M, Letteron P, Degott C, Feldmann G, Pessayre D, Fromenty B. Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice. Gastroenterology 2002;123:1278-1290.
24. Carson EJ, Pruett SB. Development and characterization of a binge drinking model in mice for evaluation of the immunological effects of ethanol. Alcohol Clin Exp Res 1996;20:132-138.
25. Nordmann R. Alcohol and antioxidant system. Alcohol Alcohol 1994;29:513-522.
26. Videla LA, Fernandez V, Valenzuela A. Age-dependent changes in rat liver lipid peroxidation and glutathione content induced by acute ethanol ingestion. Cell Biochem Funct 1987;5:273-280.
27. Trenti T, Sternieri E, Ceccarelli D, Gallesi D, Masini A. Production of lipid hydroperoxides and depletion of reduced glutathione in liver mitochondria after acute ethanol administration to rats. Toxicol Lett 1992:64/65:751-755.
28. Meagher M. Alcohol-induced generation of lipid peroxidation products in humans. J Clin Invest 1999;104:805-813.
29. Masini A, Ceccarelli D, Gallesi D, Giovannini F, Trenti T. Lipid hydroperoxide induced mitochondrial dysfunction following acute ethanol intoxication in rats. The critical role for mitochondrial reduced glutathione. Biochem Pharmacol 1994;47:217-224.
30. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969;27:502-522.
31. Flohé L, Günzler WA. Assays for glutathione peroxidase. Methods Enzymol 1984;105:114-121.
32. Habig WH, Pabst MJ, Jakoby WB. Glutathione-S-transferases, the first enzymatic step in mercapturic acid formation. J Biol Chem 1984;249:7130-7139.
33. Calberg I, Mannervik B. Glutathione reductase. Methods Enzymol 1985;113:484-490.
34. Paoletti F, Mocali A. Determination of superoxide dismutase activity by a purely chemical system based on NAD(P)H oxidation. Methods Enzymol 1990;186:209-221.
35. Claiborne A, Fridovich I. Purification of the o-dianisidine peroxidase from Escherichia coli B. Physicochemical characterization and analysis of its dual catalatic and peroxidatic activities. J Biol Chem 1979;254:4245-4252.
36. Nieto N, Friedman SL, Greenwel P, Cederbaum AI. CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells. Hepatology 1999;30:987-996.
37. Franklin CC, Krejsa CM, Pierce RH, White CC, Fausto N, Kavanagh TJ. Caspase-3-dependent cleavage of the glutamate-L-cysteine ligase catalytic subunit during apoptotic cell death. Am J Pathol 2002;160:1887-1894.
38. Reinke LA, Moyer MJ. p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol. Drug Metab Dispos 1985;13:548-552.
39. Chua SC Jr, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L, Leibel RL. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996;271:994-996.
40. Chua SC Jr, White DW, Wu-Peng XS, Liu SM, Okada N, Kershaw EE, Chung WK, Power-Kehoe L, Chua M, Tartaglia LA, Leibel RL. Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (Lepr). Diabetes 1996;45:1141-1143.
41. Shimabukuro M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y, Newgard CB, Unger RH. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci U S A 1997;94:4637-4641.
42. Samazasinghe D, Tasman-Jones C. The clinical associations with hepatic steatosis: a retrospective study. N Z Med J 1992;105:57-58.
43. Lee RG. Nonalcoholic steatohepatitis: tightening the morphological screws on a hepatic rambler. Hepatology 1995;21:1742-1744.
44. Gipp JJ, Bailey HH, Mulcahy RT. Cloning and sequence of the cDNA for the light subunit of human liver γ-glutamylcysteine synthetase. Biochem Biophys Res Commun 1995;20:584-589.
45. DeLeve L, Kaplowitz N. Glutathione metabolism and its role in hepatotoxicity. Pharmacol Ther 1991;52:287-305.
46. Mehta K, Van Thiel DH, Shah N, Mobarhan S. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev 2002;60:289-293.
47. Robertson G, Leclercq I, Farrell GC. Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol 2001;281:G1135-G1139.
48. Lieber CS. Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998)-a review. Alcohol Clin Exp Res 1999;23:991-1007.
49. Clemens MG. Nitric oxide in liver injury. Hepatology 1999;30:1-5.
50. Nanji AA, Jokelainen K, Lau GK, Rahemtulla A, Tipoe GL, Polavarapu R, Lalani EN. Arginine reverses ethanol-induced inflammatory and fibrotic changes in liver despite continued ethanol administration. J Pharmacol Exp Ther 2001;299:832-839.
51. Cook SA, Sugden PH, Clerk A. Regulation of bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential. Circ Res 1999;85:940-949.
52. Parone PA, James D, Martinou JC. Mitochondria: regulating the inevitable. Biochimie 2002;84:105-111.
53. Poulaki V, Mitsiades CS, Mitsiades N. The role of Fas and FasL as mediators of anticancer chemotherapy. Drug Resist Update 2001;4:233-242.
54. Matteoni C, Younossi ZM, McCullough A. Nonalcoholic fatty liver disease: a spectrum of clinical pathological severity. Gastroenterology 1999;116:1413-1419.
55. Caldwell SH, Oelsner DH, lezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999;29:664-669.
56. Angulo P, Keach JC, Batts KP, Lindor KP. Independent predictors of liver fibrosis in patients with non-alcoholic steatohepatitis. J Hepatol 1989;30:356-362.
57. Giraud NS, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. Hepatology 1997;25:108-111.
58. Sheth SG, Gordon FD, Chopar S. Nonalcoholic steatohepatitis. Ann Intern Med 1997;126:137-145.
59. Cope K, Risby T, Diehl AM. Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 2000;119:1340-1347.
60. Room R. Measuring alcohol consumption in the United States. In: Kozlowski LT, Annis HM, Cappell HD, Glaser FB, Goodstadt MS, Israel Y, Kalant H, Sellers EM, Vingilis ER, eds. Research advances in drug and alcohol problems. New York: Plenum Press, 1990:39-80.
61. Shaw S, Rubin KP, Lieber CS. Depressed hepatic glutathione and increased diene conjugates in alcoholic liver disease. Evidence of lipid peroxidation. Dig Dis Sci 1983;28:585-589.
62. Kawase T, Kato S, Lieber CS. Lipid peroxidation and antioxidant defense systems in rat liver after chronic ethanol feeding. Hepatology 1989;10:815-821.
63. Colell A, Garcia-Ruiz C, Morales A, Ballesta A, Ookhtens M, Rodes J, Kaplowitz N, Fernandez-Checa JC. Transport of reduced glutathione in hepatic mitochondria and mitoplasts from ethanol-treated rats: effect of membrane physical properties and S-adenosyl-L-methionine. Hepatology 1997;26:699-708.
64. Huang CS, Moore WR, Meister A. On the active site thiol of gamma-glutamylcysteine synthetase: relationships to catalysis, inhibition, and regulation. Proc Natl Acad Sci U S A 1988;85:2464-2468.
65. Polavarapu R, Spitz DR, Sim JE, Follansbee MH, Oberley LW, Rahemtulla A, Nanji AA. Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology 1998;27:1317-1323.
66. Mottaran E, Stewart SF, Rolla R, Vay D, Cipriani V, Moretti M, Vidali M, Sartori M, Rigamonti C, Day CP, Albano E. Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. Free Radic Biol Med 2002;32:38-45.
67. Woodcroft KJ, Novak RF. Insulin effects on CYP2E1, 2B, 3A, and 4A expression in primary cultured rat hepatocytes. Chem Biol Interact 1997;107:75-91.
68. Enriquez A, Leclercq I, Farrell GC, Robertson G. Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats. Biochem Biophys Res Commun 1999;255:300-306.
69. Leclercq IA, Field J, Enriquez A, Farrell GC, Robertson GR. Constitutive and inducible expression of hepatic CYP2E1 in leptin-deficient ob/ob mice. Biochem Biophys Res Commun 2000;268:337-344.
70. Leclercq IA, Farrell GC, Field J, Bell D, Gonzales FJ, Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine non-alcoholic steatohepatitis. J Clin Invest 2000;105:1067-1075.
71. Watson AM, Poloyac SM, Howard G, Blouin RA. Effect of leptin on cytochrome P-450, conjugation, and antioxidant enzymes in the ob/ob mouse. Drug Metab Dispos 1999;27:695-700.
72. Chavin KD, Yang S, Lin HZ, Chatham J, Chacko VP, Hoek JB, Walajtys-Rode E, Rashid A, Chen CH, Huang CC, Wu TC, Lane MD, Diehl AM. Obesity induces expression of uncoupling protein 2 in hepatocytes and promotes ATP depletion. J Biol Chem 1999;274:5692-5700.
73. Baraona E, Zeballos GA, Shoichet L, Mak KM, Lieber CS. Ethanol consumption increases nitric oxide production in rats, and its peroxynitrite-mediated toxicity is attenuated by polyenylphosphatidylcholine. Alcohol Clin Exp Res 2002;26:883-889.
74. Deaciuc IV, Fortunato F, D'Souza NB, Hill DB, McClain CJ. Chronic alcohol exposure of rats exacerbates apoptosis in hepatocytes and sinusoidal endothelial cells. Hepatol Res 2001;19:306-324.
75. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997;326:1-16.
76. Reed JC. Balancing cell life and death: bax, apoptosis and breast cancer. J Clin Invest 1996;97:2403-2404.